Skip to main content
Panchsheel Organic Ltd. logo

Panchsheel Organic Ltd. — Investor Relations & Filings

Ticker · 531726 ISIN · INE316G01019 BSE.NS Manufacturing
Open in API
Filings indexed 3 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS 531726

About Panchsheel Organic Ltd.

https://panchsheelorganics.com/

Panchsheel Organic Ltd. specializes in the manufacturing and export of Active Pharmaceutical Ingredients (APIs), intermediates, and finished formulations. The company provides a comprehensive range of products catering to both human and veterinary healthcare sectors. Its therapeutic portfolio includes anti-inflammatory, anti-fungal, anti-malarial, and cardiovascular agents, among others. Utilizing advanced chemical synthesis processes, the firm operates manufacturing facilities that adhere to international quality standards, including WHO-GMP certifications. The organization focuses on the production of bulk drugs and specialty chemicals, serving a diverse global client base. Key operations involve research-driven development and the supply of high-purity medicinal components for various clinical and pharmaceutical applications.

Recent filings

Filing Released Lang Actions
Panchsheel Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Approval of financial results ....
Regulatory Filings Classification · 85% confidence The document is a notice under SEBI LODR Regulation 29 informing the stock exchange of a forthcoming Board of Directors meeting to consider and approve the company’s audited results and dividend recommendation. It contains no actual financial statements or data—only an announcement of the meeting. It is not a management change, full report, or earnings release, but a routine regulatory filing. Therefore, it should be classified as a general regulatory announcement.
2026-05-26 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 85% confidence The document is a formal compliance letter addressed to the BSE confirming the company’s status under a SEBI debt securities circular. It does not contain financial results, management commentary, or substantive report data but is a regulatory compliance submission. This fits the fallback “Regulatory Filings” category.
2026-05-14 English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
Regulatory Filings Classification · 87% confidence The document is a letter/attestation from the Managing Director to the BSE confirming the company’s status under a SEBI circular on debt securities issuance. It contains no financial statements or substantive data—it is simply a regulatory compliance confirmation. It is not a report itself but a certification/filing. Therefore it falls under the “Regulatory Filings” category (RNS).
2026-05-14 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.